ALLOGENE THERAPEUTICS, INC.019770106US019770106506/18/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER6750000FOR675000FOR ALLOGENE THERAPEUTICS, INC.019770106US019770106506/18/2026To approve, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER67500001 YEAR675000FOR AMNEAL PHARMACEUTICALS, INC.03168L105US03168L105205/06/2026Advisory vote to approve executive compensation.SECTION 14A SAY-ON-PAY VOTESISSUER123287670FOR12328767FOR CHERRY HILL MORTGAGE INVESTMENT CORP.164651101US164651101406/11/2026Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers for the year ended December 31, 2025.SECTION 14A SAY-ON-PAY VOTESISSUER6255970FOR625597FOR LIFE TIME GROUP HOLDINGS, INC.53190C102US53190C102704/22/2026To approve, by a non-binding vote, the named executive officer compensation as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER28666660FOR2866666FOR LIFE TIME GROUP HOLDINGS, INC.53190C102US53190C102704/22/2026To approve, by a non-binding vote, the named executive officer compensation as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTESISSUER20719680FOR2071968FOR TPG RE FINANCE TRUST, INC.87266M107US87266M107105/19/2026Advisory Vote on Executive Compensation: To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER18451650FOR1845165FOR TPG RE FINANCE TRUST, INC.87266M107US87266M107105/19/2026Advisory Vote on Executive Compensation: To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTESISSUER5599570FOR559957FOR